The dynamics of HER2-low expression during breast cancer progression

被引：0
|
作者：
Sarah Anderson
Brooke Baxter Bartow
Gene P. Siegal
Xiao Huang
Shi Wei
机构：
[1] The University of Alabama at Birmingham,Department of Pathology
[2] The University of Kansas Medical Center,Department of Pathology and Laboratory Medicine
来源：
Breast Cancer Research and Treatment | 2023年 / 201卷
关键词：
Breast cancer; HER2-low; Immunohistochemistry; In situ hybridization; Amplification; Overexpression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 446
页数：9
相关论文
共 50 条
  • [41] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
  • [42] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Nanae Horisawa
    Yayoi Adachi
    Daiki Takatsuka
    Kazuki Nozawa
    Yuka Endo
    Yuri Ozaki
    Kayoko Sugino
    Ayumi Kataoka
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Masataka Sawaki
    Hiroji Iwata
    Breast Cancer, 2022, 29 : 234 - 241
  • [43] HER2-Low and Ultra-Low expression in young women with luminal breast cancer in Mexico
    Hernandez, Jesus Edgardo Hernandez
    Torres, Cesar Octavio Lara
    Moran, Bryan Moreno
    Garza, Cynthia Villareal
    Reyes, Fany Iris Porras
    Sanchez, Victor Manuel Perez
    Mohar, Alejandro
    CANCER RESEARCH, 2024, 84 (09)
  • [44] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Mengyuan Cai
    Ming Li
    Hong Lv
    Shuling Zhou
    Xiaoli Xu
    Ruohong Shui
    Wentao Yang
    BMC Cancer, 23
  • [45] HER2-Low Breast Cancer: Evolution of HER2 expression from Primary Tumor to Distant Metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S107 - S109
  • [46] HER2-low breast cancer: a new concept in breast cancer treatment strategy
    Deluche, Elise
    Vincent-Salomon, Anne
    BULLETIN DU CANCER, 2021, 108 (11) : S1 - S7
  • [47] The clinicopathological and prognostic significance of HER2-low breast cancer: A comparative analysis between HER2-low and HER2-zero subtypes
    Nishimura, Reiki
    Fujiki, Yoshitaka
    Taira, Tetsuhiko
    Miyaki, Toshiko
    Kanemitsu, Shuichi
    Yotsumoto, Daisuke
    Teraoka, Megumi
    Kawano, Junko
    Gondo, Naomi
    Mitsueda, Reiko
    Baba, Shinichi
    Ohi, Yasuyo
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    CANCER RESEARCH, 2024, 84 (09)
  • [48] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [49] HER2-low breast cancer: Evolution from primary breast cancer to relapse
    Miglietta, F.
    Griguolo, G.
    Bottosso, M.
    Giarratano, T.
    Lo Mele, M.
    Fassan, M.
    Cacciatore, M.
    Genovesi, E.
    De Bartolo, D.
    Vernaci, G.
    Conte, P. F.
    Guarneri, V.
    Dieci, M. V.
    ANNALS OF ONCOLOGY, 2021, 32 : S23 - S23
  • [50] Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
    Mutai, Raz
    Barkan, Tamar
    Moore, Assaf
    Sarfaty, Michal
    Shochat, Tzippy
    Yerushalmi, Rinat
    Stemmer, Salomon M.
    Goldvaser, Hadar
    BREAST, 2021, 60 : 62 - 69
12345